MENDiP: Measurements of Overnight Penile Temperature to Evaluate Nocturnal Erection Detection in Patients With Absence of Erectile Functioning After Robot-assisted Radical Prostatectomy
MENDiP
1 other identifier
observational
15
1 country
1
Brief Summary
Nocturnal erection detection with the outdated RigiScan is the golden standard for erectile dysfunction (ED) nature differentiation. The Staying Hot and Feeling Hot study have shown that nocturnal erection detection is feasible with patient-friendly overnight penile temperature measurements. The question has arisen whether the penile temperature methodology is also capable to detect the absence of nocturnal erections, which is essential for clinical implementation in erectile dysfunction diagnostics. The objective of the MENDiP-study is to determine the feasibility to detect the absence of nocturnal erections with overnight penile temperature sensors. Furthermore, the MENDiP study functions as a first pilot trial to investigate the effect of age on the penile temperature during nocturnal erections in test subjects with normal erectile functioning. This is done in an observational study with a longitudinal design in which pre- and postoperative ambulatory overnight measurements are performed in patients, aged 55 - 70 years with preoperative normal sexual functioning, undergoing a non- or unilateral nerve-sparing robot assisted radical prostatectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2022
CompletedFirst Posted
Study publicly available on registry
October 13, 2022
CompletedStudy Start
First participant enrolled
January 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2023
CompletedOctober 13, 2022
October 1, 2022
5 months
October 10, 2022
October 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Detectability absence nocturnal erections
Visual detectability of the presence and absence of nocturnal erections in overnight penile temperature measurements
9 hours
Penile temperature REM-sleep
Maximal variation in penile temperature during REM-sleep in case of presence and absence of nocturnal erections
9 hours
Penile temperature nocturnal erection
Maximal variation in penile temperature during nocturnal erections in men aged 55 - 70 years
9 hours
Other Outcomes (1)
Demographic data
1 year
Study Arms (3)
Group 1
Age 55 - 60 years
Group 2
Age 60 - 65 years
Group 3
Age 65 - 70 years
Interventions
The Feeling Hot sensor is a proof-of-concept system, which can measure overnight penile, thigh and air temperature.
Eligibility Criteria
Fifteen patients, aged 55 - 70 years, who will undergo a non- or unilateral-nerve-sparing robot assisted radical prostatectomy will be included in case preoperative normal erectile functioning and postoperative complete impotence at three months after surgery.
You may qualify if:
- Preoperative measurement:
- Aged 55 - 70 years
- Prostatecancer patients undergoing a non-/unilateral-nerve-sparing radical prostatectomy (RARP)
- Pre-operative IIEF-5 score \> 21
- Postoperative measurement
- Preoperative penile temperature increase during first nocturnal erection of minimally 0.4 degrees Celsius
- Post-operative IIEF-5 score \< 12 with absence of morning erections
You may not qualify if:
- Test subjects who are unwilling to sign informed consent
- Test subjects with erectile dysfunction before RARP (IIEF-5 score of below 22)
- (History of) sickle cell aneamia, atherosclerosis and diabetes type I or II. These conditions might influence penile blood circulation and therefore the accuracy of the study outcomes.
- (History of) REM-sleep behavior disorder or other sleep disorders such as restless legs syndrome, insomnia, and sleep apnea
- Usage of sleeping pills or benzodiazepines.
- Postoperative results will be excluded from the study in case of presence of nocturnal erections according to the RigiScan data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Antonius Ziekenhuis
Nieuwegein, Utrecht, 3435CM, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jack Beck, dr., MD
Urologist
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSc.
Study Record Dates
First Submitted
October 10, 2022
First Posted
October 13, 2022
Study Start
January 18, 2023
Primary Completion
June 30, 2023
Study Completion
October 10, 2023
Last Updated
October 13, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share